These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 908456)

  • 1. The spontaneous release of 51Cr from labeled EL-4 ascitic lymphoma cells as dependent upon the composition of the cell population.
    DeBernardo E; Claus G; Krisko I
    Exp Cell Biol; 1977; 45(3-4):122-40. PubMed ID: 908456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of cell-mediated immune lysis of the EL-4 ascitic lymphoma on its population composition and rhythm.
    De Bernardo E; Bolander K; Claus G
    Exp Cell Biol; 1978; 46(4):246-54. PubMed ID: 640124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malvidin Abrogates Oxidative Stress and Inflammatory Mediators to Inhibit Solid and Ascitic Tumor Development in Mice.
    Sakthivel KM; Kokilavani K; Kathirvelan C; Brindha D
    J Environ Pathol Toxicol Oncol; 2020; 39(3):247-260. PubMed ID: 32865916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
    Rembelska MJ; Liniecki J
    Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity and antioxidant status of the methanol extract of Careya arborea bark against Dalton's lymphoma ascites-induced ascitic and solid tumor in mice.
    Natesan S; Badami S; Dongre SH; Godavarthi A
    J Pharmacol Sci; 2007 Jan; 103(1):12-23. PubMed ID: 17251685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the growth of an ascitic tumour. I. Cellular and subcellular changes during the tumour growth.
    Kopper L; Jeney A; Takács J; Benedeczky I; Dzurillay E; Lapis K
    Eur J Cancer (1965); 1978 Jan; 14(1):59-73. PubMed ID: 624304
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.
    Nagy JA; Herzberg KT; Dvorak JM; Dvorak HF
    Cancer Res; 1993 Jun; 53(11):2631-43. PubMed ID: 8495427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of soluble β-(1-3),(1-6)-D-glucan from Saccharomyces cerevisiae in the murine P388 ascites tumor model.
    Harnack U; Eckert K; Pecher G
    In Vivo; 2011; 25(2):185-9. PubMed ID: 21471533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with nucleoside transport in mouse lymphoma cells proliferating in culture.
    Warnick CT; Muzik H; Paterson AR
    Cancer Res; 1972 Oct; 32(10):2017-22. PubMed ID: 4673140
    [No Abstract]   [Full Text] [Related]  

  • 10. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
    Wiltrout RH; Frost P; Cummings GD
    J Natl Cancer Inst; 1978 Jul; 61(1):183-8. PubMed ID: 97392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascitic lymphoma.
    Christina AJ; Joseph DG; Packialakshmi M; Kothai R; Robert SJ; Chidambaranathan N; Ramasamy M
    J Ethnopharmacol; 2004 Aug; 93(2-3):359-61. PubMed ID: 15234777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal and kinetic effects of peptichemio on cultured human lymphoma cells.
    Barlogie B; Drewinko B; Göhde W; Bodey GP
    Cancer Res; 1977 Aug; 37(8 Pt 1):2583-8. PubMed ID: 872086
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental biotherapy by leptospiral infection. IX. Quantitative titration of the tumoricidal effect of leptospiral exoproducts by means of 51Cr-labeled target cells of mouse ascites tumors.
    Oravec C; Kmety E
    Neoplasma; 1981; 28(6):705-8. PubMed ID: 7339498
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplantable lymphoma producing type K Bence-Jones protein in NZB mouse.
    Yumoto T; Okamoto S
    Acta Pathol Jpn; 1977 May; 27(3):359-73. PubMed ID: 920175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA synthesis in fast- and slow-growing C57BL ascites tumors.
    Maruyama Y; Gedgaudes RK; Lee TC; Yung WK
    Cancer Res; 1974 Oct; 34(10):2580-4. PubMed ID: 4412879
    [No Abstract]   [Full Text] [Related]  

  • 16. Partial purification of a normal mice serum sugar-phosphatase inhibitor from cell-free ascites fluids of lymphoma-bearing mice. In vitro and in vivo effects.
    Raimond-Pironneau F; Morel E
    Biochimie; 1980; 62(2-3):187-90. PubMed ID: 6246966
    [No Abstract]   [Full Text] [Related]  

  • 17. Resting cells in L1210 and JB-1 ascites tumors with special emphasis on recycling.
    Hartmann NR; Dombernowsky P; Bichel P
    Cancer Treat Rep; 1976 Dec; 60(12):1861-70. PubMed ID: 1026340
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic evidence for and implications of cell age cohort variation during tumor growth.
    Maruyama Y; Lee TC
    Cancer; 1972 Jul; 30(1):84-90. PubMed ID: 5040747
    [No Abstract]   [Full Text] [Related]  

  • 19. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.
    Ralph P; Prichard J; Cohn M
    J Immunol; 1975 Feb; 114(2 pt 2):898-905. PubMed ID: 1089721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.